KLP Kapitalforvaltning’s Cidara Therapeutics CDTX Stock Holding History

KLP Kapitalforvaltning’s Portfolio CDTX Stock Details CDTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2,500	Closed	-$552K	–	2165
2025 Q4	$552K	Hold	2,500	–	–	﹤0.01%	1364
2025 Q3	$239K	Buy	+2,500	New	+$160K	﹤0.01%	1750

KLP Kapitalforvaltning's CDTX Position: Q1 2026 in Review

KLP Kapitalforvaltning sold out of Cidara Therapeutics (CDTX) in Q1 2026, closing a stake of 2,500 shares — an estimated $552K sold.

KLP Kapitalforvaltning first reported a position in CDTX in Q3 2025 and held it in 2 quarters. The position peaked at $552K in Q4 2025. 0 funds tracked by Wall St. Rank hold CDTX as of Q1 2026.

KLP Kapitalforvaltning reported no remaining Cidara Therapeutics position as of Q1 2026 after selling out during the quarter.
KLP Kapitalforvaltning sold 2,500 Cidara Therapeutics shares in Q1 2026, an estimated $552K.
KLP Kapitalforvaltning first reported a position in Cidara Therapeutics in Q3 2025 and held it in 2 quarters.
KLP Kapitalforvaltning's Cidara Therapeutics position peaked at $552K in Q4 2025.
0 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q1 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q1 2026, filed 29 Apr 2026.